These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 34874565

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H, Li PW, Yang WQ, Mi H, Pan JL, Huang YC, Hou ZK, Hou QK, Luo Q, Liu FB.
    BMC Cancer; 2019 Feb 08; 19(1):129. PubMed ID: 30736753
    [Abstract] [Full Text] [Related]

  • 6. Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance.
    Feng Y, Zhong M, Zeng S, Wang L, Liu P, Xiao X, Liu Y.
    Epigenomics; 2019 Jan 08; 11(1):35-51. PubMed ID: 30211623
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L, Li Y.
    Oncotarget; 2017 Feb 21; 8(8):13048-13058. PubMed ID: 28055956
    [Abstract] [Full Text] [Related]

  • 11. Effect of rituximab combined with chemotherapy on the expression of serum exosome miR-451a in patients with diffuse large b-cell lymphoma.
    Xiao XB, Gu Y, Sun DL, Ding LY, Yuan XG, Jiang HW, Wu ZX.
    Eur Rev Med Pharmacol Sci; 2019 Feb 21; 23(4):1620-1625. PubMed ID: 30840285
    [Abstract] [Full Text] [Related]

  • 12. The Roles of Exosomal microRNAs in Diffuse Large B-Cell Lymphoma: Diagnosis, Prognosis, Clinical Application, and Biomolecular Mechanisms.
    Yazdanparast S, Huang Z, Keramat S, Izadirad M, Li YD, Bo L, Gharehbaghian A, Chen ZS.
    Front Oncol; 2022 Feb 21; 12():904637. PubMed ID: 35719983
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma.
    Han Z, Li Y, Zhang J, Guo C, Li Q, Zhang X, Lan Y, Gu W, Xing Z, Liang L, Li M, Mi S.
    Int J Med Sci; 2020 Feb 21; 17(10):1428-1438. PubMed ID: 32624699
    [Abstract] [Full Text] [Related]

  • 15. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
    Li S, Hao H, Li R, Guo S.
    Tohoku J Exp Med; 2022 Mar 21; 256(3):215-223. PubMed ID: 35314529
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer.
    Zheng B, Peng M, Gong J, Li C, Cheng H, Li Y, Tang Y.
    Exp Biol Med (Maywood); 2023 Aug 21; 248(16):1403-1413. PubMed ID: 37551102
    [Abstract] [Full Text] [Related]

  • 19. Identification and evaluation of circulating exosomal miRNAs for the diagnosis of postmenopausal osteoporosis.
    Sun Z, Shi J, Yang C, Chen X, Chu J, Chen J, Wang Y, Zhu C, Xu J, Tang G, Shao S.
    J Orthop Surg Res; 2023 Jul 26; 18(1):533. PubMed ID: 37496029
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.